The Latest Updates from ReSPECT Clinical Trials

Did You Know: LM Fact

Jan 10, 2025

Did You Know? Leptomeningeal Metastases (LM) Rise From Various Cancers Leptomeningeal metastases (LM) is a serious condition where cancer cells spread to the leptomeninges, the membranes that cover the brain and spinal cord. While any cancer can metastasize to the...

read more

ReSPECT-LM Locations

Jan 7, 2025

🚀 Plus Therapeutics Doubles ReSPECT-LM Clinical Trial Locations in 2024 Plus Therapeutics is proud to announce that we have doubled the number of locations for our ReSPECT-LM clinical trial in 2024, expanding to 6 investigation sites nationwide. This significant...

read more

Happy New Year 2025!

Jan 2, 2025

🎉 Happy New Year from Plus Therapeutics! 🎉 As we ring in the new year, we want to extend our heartfelt gratitude to the patients, medical staff, and the entire cancer community who have supported our mission throughout 2024. Thanks to your dedication and hard work,...

read more

Brains for the Cure

Jan 1, 2025

ReSPECT Clinical Trials on BrainsFortheCure.org What is Recurrent Glioblastoma (GBM)? Recurrent glioblastoma is a particularly aggressive form of brain cancer that tends to return after initial treatment. GBM recurrence is a major challenge for both patients and...

read more

NOW ONLINE: SNO 2024 Presentations

Dec 25, 2024

Missed Plus Therapeutics at SNO Annual 2024? Catch Our Latest Presentations Online – Including ReSPECT-LM Phase 1 Interim Data If you weren’t able to attend the SNO Annual Meeting 2024 this year, don’t worry – you can now access all our key presentations online! This...

read more

Happy Holidays 2024

Dec 23, 2024

🎄 Happy Holidays from Plus Therapeutics! 🎄 As the end of year year approaches, the Plus Therapeutics team wants to extend our warmest holiday greetings to all of our patients, partners, and supporters. We are taking some time this week to relax and recharge with our...

read more

WATCH NOW: ReSPECT-GBM Patient Story

Dec 19, 2024

🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor Watch Jim's Inspiring Story Now on YouTube: Watch Jim's Story Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to inspiring...

read more

New GBM Site: North Shore

Dec 18, 2024

❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗ We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under...

read more

ReSPECT-LM at SABCS Presentation

Dec 17, 2024

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data at 2024 San Antonio Breast Cancer Symposium (SABCS) ICYMI: Plus Therapeutics presented our ReSPECT-LM Phase 1 interim data for Breast Cancer patients with Leptomeningeal Metastases at the 2024 San...

read more

COMING SOON: ReSPECT-GBM Patient Video

Dec 16, 2024

COMING SOON: A Glioblastoma Survivor’s Journey with ReSPECT-GBM This week, we are thrilled to share a BRAND NEW patient testimonial from Jim, a courageous individual who has been navigating the challenges of recurrent glioblastoma. In this powerful video, Jim...

read more

SABCS 2024 Booth

Dec 11, 2024

Reminder: Visit Plus Therapeutics at #SABCS2024 in San Antonio – Booth #1542! Join us at #SABCS2024 in San Antonio, Texas, where Plus Therapeutics will be showcasing its groundbreaking work in targeted radiation therapy for central nervous system cancers including...

read more

WATCH NOW: Leptomeningeal Metastases SNO Symposium

Dec 9, 2024

⏯️ 🧠 Now Streaming: Replay the Live Symposium by Plus Therapeutics at #SNO2024 Annual Conference Catch up on the latest advancements in leptomeningeal disease and cancer therapeutics! The live symposium presented by Plus Therapeutics at the #SNO2024 Annual Meeting is...

read more

A ReSPECT-LM Patient Story

Dec 5, 2024

🎗️ Now Streaming: A ReSPECT-LM Patient Story | Marlyn, Leptomeningeal Metastases Survivor ⏯️ Watch her inspiring journey on YouTube: A ReSPECT-LM Patient Story: Marlyn’s Journey At the age of 31, while immersed in her Medical Residency for Pediatrics, Dr. Marlyn...

read more

COMING SOON: ReSPECT-LM at SABCS 2024

Dec 4, 2024

Exciting News: ReSPECT-LM Leptomeningeal Metastases Clinical Trial to be Showcased at SABCS 2024! Mark your calendars! Plus Therapeutics is thrilled to present groundbreaking data from our ReSPECT-LM Phase 1 clinical trial at the 2024 San Antonio Breast Cancer...

read more

COMING SOON: ReSPECT-LM MBC Patient Video

Dec 2, 2024

Inspiring Metastatic Breast Cancer Story: Marlyn’s Journey with Leptomeningeal Metastases The wait is almost over! This week, we are thrilled to release a brand new patient testimonial from one of our courageous ReSPECT-LM patients. In this powerful video, Marlyn...

read more

Happy Thanksgiving!

Nov 28, 2024

Thankful for the Oncology Community: Celebrating Patients, Caregivers, and Medical Advancements As we take time to reflect on the progress in the field of oncology, Plus Therapeutics extends our deepest gratitude to the patients, caregivers, and the dedicated medical...

read more

FORESEE Data at SNO 2024

Nov 22, 2024

Plus Therapeutics to Present Positive FORESEE Clinical Trial Data at SNO Annual Meeting in Houston Plus Therapeutics is thrilled to present groundbreaking results from the FORESEE Clinical Trial at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston. The...

read more

Reminder: SNO Annual 2024 Symposium

Nov 22, 2024

Don’t Miss the SNO Annual Symposium Tomorrow – RSVP and Request a Recording! Reminder: The SNO Annual Meeting is TOMORROW (11/23)! If you can’t attend in person, or if you’d like to review the content later, you can RSVP for the presentation and request a recording of...

read more

JOIN US: SNO Annual 2024 Booth

Nov 21, 2024

Visit Plus Therapeutics at the SNO Annual Meeting in Houston – Booth #317/319 Reminder: Plus Therapeutics will be showcasing its groundbreaking radiotherapeutic advancements at the Society for Neuro-Oncology (SNO) Annual Meeting in Houston! Be sure to stop by our...

read more